RENFLEXIS™ has been added to drug formulary for the treatment of adult and pediatric Crohn’s disease and ulcerative colitis, as well as for the treatment of fistulising Crohn’s disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis in adults.
August 22, 2018
· 6 min read